Drug Science publishes peer reviewed research, reports, and articles to provide clear, evidence-based information without political or commercial interference.

Authors Ben Houghton, Alexis Bailey, Christos Kouimtsidis, Theodora Duka, Caitlin Notley Published November 25, 2021 Background Opioid-related deaths are at record levels in the UK and contribute to over half of all drug-related deaths. The prevalence of psychiatric disorders within people who uses substances is known to be considerably higher than…

Is LSD Safe? LSD, technically named lysergic acid diethylamide and also known as acid, is one of the most widely used psychedelic drugs. As it changes both your cognition and your perception, it's natural to assume this comes with an element of risk and yet LSD is widely regarded to be…

Get Project Twenty21 Updates via Email It’s certainly been an eventful past month for Project Twenty21! Drug Science and its supporters celebrated its achievements to date at the House of Lords in mid-October, which included a moving speech from our patient advocate, Lucy Stafford, detailing her journey with medical cannabis.  As Medical…

Schedule 1 barriers to research in the UK: An in-depth qualitative analysis

Authors Annie Howard, Joanna C Neill, Anne Katrin Schlag, Charlotte Lennox Published October 25, 2021 Prior to the 1970s, psychedelics such as LSD were used and researched extensively. However, with the introduction of the UN convention Misuse of Drugs Regulations in 2001, all drugs were placed into one of five categories…

Get Project Twenty21 Updates via Email   We're pleased to finally be able to announce that Attention Deficit Hyperactivity Disorder (ADHD) in adults has now been added to the list of indications covered by the study. This means that we will be able to start collecting data on how medical cannabis affects…